Non-invasive brain stimulation for swallowing recovery after a dysphagic stroke
无创脑刺激促进吞咽困难中风后吞咽恢复
基本信息
- 批准号:9061404
- 负责人:
- 金额:$ 54.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-06-14 至 2018-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdverse eventAspiration PneumoniaAssessment toolBehaviorBrainBrain StemBrain imagingCaringCessation of lifeClinicalClinical ResearchCohort StudiesComplicationCorticobulbar TractsDataDeglutitionDeglutition DisordersDeteriorationDietDoseEatingExerciseFoundationsFutureGastrointestinal HemorrhageGastrostomyHealthImaging TechniquesImpairmentIncidenceInfarctionInjuryIntakeInterventionLeadLesionLocationMeasuresMediatingModelingMotor CortexNeurologicOralOutcomePathway interactionsPatient SelectionPatient-Focused OutcomesPatientsPenetrationPersonsPhasePhysiologicalPhysiologyPilot ProjectsRecoveryResearchResearch DesignRiskSafetySeizuresSeveritiesStrokeSubgroupTechniquesTubeUnited States National Institutes of Healthacute strokechronic strokeclinically relevantcosteffective therapyexperienceimprovedimproved functioninginclusion criteriaintervention effectmortalityneuroimagingneuronal excitabilityneuroregulationnovelnutritionpreventprospectiveresponsetreatment response
项目摘要
DESCRIPTION (provided by applicant): Project Summary: Swallowing impairments are a common and a serious complication of stroke but lack effective therapies. We herein propose to conduct a prospective clinical study using a non-invasive brain stimulation technique, anodal transcranial direct current stimulation (tDCS), in combination with swallowing exercises for improving dysphagia due to an acute-subacute hemispheric infarction, and obtain data on safety and effect of 2 different doses of tDCS, on swallowing physiology and behavior. Dysphagia from hemispheric strokes occurs due to disruption of the cortical projections to the brainstem swallowing centers while recovery of swallowing functions have been shown to be mediated via the reorganization of the swallowing cortex in the unaffected hemisphere. Our recent pilot study demonstrates that application of 5 consecutive daily sessions of anodal tDCS for 30 minutes to the swallowing cortex on the unaffected hemisphere is safe and feasible in the acute-subacute stroke phases and shows a promise in improving dysphagia, when combined concomitantly with swallowing exercises. The proposed research will be used to further confirm safety of this technique in early stroke phases and explore alternative, more effective doses for promoting swallowing recovery prior to its examination in any confirmatory trials. We will use our study cohort to examine important subject-specific parameters which influence response to our proposed intervention in dysphagic stroke patients. The overall aim of this study is to gather additional safety data on cumulative sessions of tDCS in acute-subacute phases of stroke, obtain information about effects of this intervention on important physiological and clinically relevant swallowing parameters, examine possible dose effects, and identify candidates who are more likely to benefit from this intervention. The experience gained from this project will guide planning of future confirmatory trials that use relevant clinical outcomes to assess potential benefits of this intervention and utilize important subject- specific parameters to refin study inclusion criteria and aid in severity adjusted analysis.
描述(由申请人提供): 项目摘要:吞咽障碍是中风常见且严重的并发症,但缺乏有效的治疗方法。我们在此建议进行一项前瞻性临床研究,使用非侵入性脑刺激技术,阳极经颅直流电刺激(tDCS),结合吞咽练习来改善急性亚急性半球梗死引起的吞咽困难,并获得两种不同剂量的tDCS对吞咽生理和行为的安全性和影响的数据。半球中风引起的吞咽困难是由于脑干吞咽中心的皮层投射破坏而发生的,而吞咽功能的恢复已被证明是通过未受影响的半球吞咽皮层的重组来介导的。我们最近的初步研究表明,在急性-亚急性卒中阶段,每天连续 5 次对未受影响半球的吞咽皮层进行 30 分钟的阳极 tDCS 治疗是安全可行的,并且与吞咽练习相结合,有望改善吞咽困难。拟议的研究将用于进一步确认该技术在中风早期阶段的安全性,并在任何验证性试验中进行检查之前探索替代的、更有效的剂量来促进吞咽恢复。我们将利用我们的研究队列来检查重要的特定于受试者的参数,这些参数会影响我们对吞咽困难中风患者提出的干预措施的反应。本研究的总体目的是收集关于中风急性-亚急性期 tDCS 累积疗程的额外安全性数据,获取有关该干预措施对重要生理和临床相关吞咽参数的影响的信息,检查可能的剂量效应,并确定更有可能从该干预措施中受益的候选人。从该项目中获得的经验将指导未来验证性试验的规划,这些验证性试验使用相关的临床结果来评估该干预措施的潜在益处,并利用重要的受试者特定参数来完善研究纳入标准并帮助进行严重性调整分析。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sandeep Kumar其他文献
Sandeep Kumar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sandeep Kumar', 18)}}的其他基金
Non-invasive brain stimulation for swallowing recovery after a dysphagic stroke
无创脑刺激促进吞咽困难中风后吞咽恢复
- 批准号:
8682889 - 财政年份:2013
- 资助金额:
$ 54.04万 - 项目类别:
Non-invasive brain stimulation for swallowing recovery after a dysphagic stroke
无创脑刺激促进吞咽困难中风后吞咽恢复
- 批准号:
8504604 - 财政年份:2013
- 资助金额:
$ 54.04万 - 项目类别:
相似海外基金
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10707830 - 财政年份:2023
- 资助金额:
$ 54.04万 - 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
- 批准号:
479728 - 财政年份:2023
- 资助金额:
$ 54.04万 - 项目类别:
Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
- 批准号:
10884567 - 财政年份:2023
- 资助金额:
$ 54.04万 - 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
- 批准号:
10751964 - 财政年份:2023
- 资助金额:
$ 54.04万 - 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
- 批准号:
486321 - 财政年份:2022
- 资助金额:
$ 54.04万 - 项目类别:
Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10676786 - 财政年份:2022
- 资助金额:
$ 54.04万 - 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10440970 - 财政年份:2022
- 资助金额:
$ 54.04万 - 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
- 批准号:
10642998 - 财政年份:2022
- 资助金额:
$ 54.04万 - 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10482465 - 财政年份:2022
- 资助金额:
$ 54.04万 - 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
- 批准号:
10191053 - 财政年份:2020
- 资助金额:
$ 54.04万 - 项目类别: